Results 151 to 160 of about 351,954 (346)
Pregnancy and Its Successful Outcome in a Patient with Multiple Myeloma
, 2020 Akanksha Garg +2 more
openalex +2 more sources
Extracellular vesicle‐based vaccines and immunotherapeutics for treatment of cancer
Interdisciplinary Medicine, EarlyView.This review highlights the innovative value of extracellular vesicles (EVs) as cancer vaccines and immunotherapy carriers. EVs have natural advantages such as low immunogenicity, high biocompatibility, stability, and precise targeting, enabling efficient delivery of tumor antigens (e.g., HER2, AFP) and immune stimulants (e.g., TLR ligands, cytokines ...
Lejia Tan +4 more
wiley +1 more source
I-OPen: inferior outcomes of penta-refractory compared to penta-exposed multiple myeloma patients
Blood Cancer Journal, 2022 Sarvarinder K. Gill +9 more
doaj +1 more source
Journal of Medical Radiation Sciences, EarlyView.This study developed standardised Medical Imaging Suite (MIS) request and contrast consent forms, modelled on real‐world documentation, to enhance student learning in diagnostic radiography education. By analysing forms from n = 25 medical imaging providers, key fields were identified and incorporated into authentic teaching resources, intended for use
Don J. Nocum +2 more
wiley +1 more source
Cytogenetics of Multiple Myeloma [PDF]
, 2010 Great studies of multiple myeloma (MM) strongly suggested that specific chromosomal changes are of prognostic significance in patients with MM1. We have performed cytogenetic analysis and recently fluorescent in situ hybridization (FISH) on 43 cases of ...
Ana Planinc-Peraica +7 more
core +1 more source
Journal of Periodontology, EarlyView.Abstract Background Recent advancements in bone tissue biomarker research have identified 2 promising molecules: Dickkopf‐1 and secreted Frizzled‐Related Protein 5. This study aims to evaluate the levels of these biomarkers in gingival crevicular fluid in periodontal health, gingivitis, and periodontitis and to assess the effects of non‐surgical ...
Sukran Acipinar, Kubilay Baris
wiley +1 more source
Dupilumab and Systemic Hematologic Malignancies: Case Series and Literature Review
JEADV Clinical Practice, EarlyView.ABSTRACT Background Atopic dermatitis (AD) is a chronic inflammatory skin disease affecting 15%–20% of children and 3%–10% of adults. An increased risk of systemic lymphomas – but not leukemias – has been reported in patients with AD. Dupilumab, a monoclonal IgG4 antibody targeting IL‐4 and IL‐13 signaling, is approved for moderate‐to‐severe AD and is ...
Nello Tommasino +3 more
wiley +1 more source